This is the logo of the provider
ADA 2025 20 - 23 June 2025

Efficacy and Safety of Semaglutide 7.2 mg in Obesity: The STEP UP Trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Obesity
Congress poster
GLP-1 RA
Semaglutide
PHASE 3 (RCT)